Enrollment of older adults on oncology trials: An FDA perspective

被引:39
|
作者
Singh, Harpreet [1 ]
Beaver, Julia A. [1 ]
Kim, Geoffrey [1 ]
Pazdur, Richard [1 ]
机构
[1] US FDA, Off Hematol & Oncol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA
关键词
D O I
10.1016/j.jgo.2016.11.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
下载
收藏
页码:149 / 150
页数:2
相关论文
共 50 条
  • [1] Enrollment of older adults in clinical trials for oncology indications, 2010-2020: An evaluation by the FDA
    Yang, Felice
    Lerro, Catherine C.
    Feng, Zhou
    Akinboro, Oladimeji
    Curley, Richard
    Dilawari, Asma Ali
    Fiero, Mallorie
    Huang, Yue
    Ison, Gwynn
    Kanapuru, Bindu
    Leong, Ruby
    Liu, Wei
    Patel, Timil
    Suzman, Daniel L.
    Kluetz, Paul Gustav
    Singh, Harpreet
    Rivera, Donna
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Regulatory considerations on the enrollment of older adults in oncology clinical trials
    Raimi-Abraham, Bahijja Tolulope
    de Orbe Izquierdo, Maria Silvia
    Collignon, Olivier
    Cerreta, Frahcesca
    JOURNAL OF GERIATRIC ONCOLOGY, 2017, 8 (03) : 151 - 153
  • [3] Enrollment of Older Adults in Clinical Trials Evaluating Patients with Hematologic Malignancies - the Food and Drug Administration (FDA) Experience
    Kanapuru, Bindu
    Singh, Harpreet
    Myers, Adrian
    Beaver, Julia A.
    Kwitkowski, Virginia Elaine
    Farrell, Ann T.
    Pazdur, Richard
    BLOOD, 2017, 130
  • [4] Imaging as a tumor biomarker in oncology drug trials for lung cancer: The FDA perspective
    Petrick, N.
    Brown, D. G.
    Suleiman, O.
    Myers, K. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (04) : 523 - 525
  • [5] FDA analysis of enrollment of older adults in clinical trials for cancer drug registration: A 10-year experience by the US Food and Drug Administration.
    Singh, Harpreet
    Kanapuru, Bindu
    Smith, Che
    Fashoyin-Aje, Lola A.
    Myers, Adrian
    Kim, Geoffrey
    Pazdur, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Precision Medicine: FDA Oncology Perspective
    Blumenthal, Gideon
    ANNALS OF ONCOLOGY, 2019, 30
  • [7] Evaluation of Enrollment in Oncology Phase I Clinical Trials
    van der Biessen, A. J.
    Cranendonk, M. A.
    van der Holt, B.
    Verweij, J.
    de Jonge, M. J. A.
    Mathijssen, R. H. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S161 - S161
  • [8] EXAMINING MINORITY ENROLLMENT IN CLINICAL TRIALS IN UROLOGIC ONCOLOGY
    Owens-Walton, Jeunice
    Williams, Cheyenne
    Rompre-Brodeur, Alexis
    Pinto, Peter
    Ball, Mark W.
    JOURNAL OF UROLOGY, 2021, 206 : E749 - E749
  • [9] Barriers to enrollment in clinical trials in gynecologic oncology.
    McMinn, Erin
    Smith, Anna Jo Bodurtha
    Arasappan, Dhivya
    Koelper, Nathanael
    Simpkins, Fiona
    Howell, Elizabeth A.
    Ko, Emily Meichun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] A Call to Action: Radiation Oncology Trials and Minority Enrollment
    Kesarwala, Aparna H.
    Godette, Karen D.
    Bradley, Jeffrey D.
    PRACTICAL RADIATION ONCOLOGY, 2021, 11 (06) : 460 - 462